Filgotinib Improved Health-Related Quality of Life and Led to Comprehensive Disease Control in Individuals with Ulcerative Colitis: Data from SELECTION.

Stefan SchreiberBrian G FeaganLaurent Peyrin-BirouletSéverine VermeireMargaux FaesKristina HarrisAlessandra OortwijnPatrick DanieleHaridarshan PatelSilvio Danese

Published in: Journal of Crohn's & colitis (2023)

Filgotinib 200 mg results in short- and long-term improvements in HRQoL. High level improvement of HRQoL relates to a stringent composite endpoint suggesting meaningful disease control in a subset of filgotinib-treated individuals.

Keyphrases

ulcerative colitis
machine learning
newly diagnosed
artificial intelligence
data analysis